StockData
Immunic, Inc. logo

Immunic, Inc. (IMUX) shareholders

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.33+0.10 (+1.38%)

Close on Nov 17, 2026Market cap $100.01MP/E –Yield 0.00%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
63.7%
9M of 14M shares
Institutional holders
55
11 new, 33 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Vivo Opportunity, LLC
Joint filing with Vivo Opportunity Fund Holdings, L.P. (9.99%), Vivo Opportunity Cayman Fund, L.P. (9.99%) and 1 more
29,126,9069.99%13G (passive)Feb 17, 2026
Avidity Private Master Fund I LP
Joint filing with Avidity Partners Management LP (9.90%), Avidity Partners Management (GP) LLC (9.90%) and 3 more
13,958,4109.90%13G (passive)Feb 17, 2026
Lampert Mark N
Joint filing with Bvf Partners L P/Il (9.99%), Bvf Inc/Il (9.99%) and 3 more
13,630,6019.99%13D (active)Feb 12, 2026
Commodore Capital Master LP
Joint filing with Commodore Capital LP (9.90%), Robert Egen Atkinson (9.90%) and 1 more
13,350,1219.90%13G (passive)Feb 17, 2026
Janus Henderson Group PLC12,016,4449.99%13G (passive)Nov 28, 2025
Deep Track Capital, LP
Joint filing with David Kroin (8.69%), Deep Track Biotechnology Master Fund, Ltd. (6.79%)
11,454,0008.69%13G (passive)Feb 17, 2026
Trails Edge Capital Partners, LP
Joint filing with Trails Edge Biotechnology Master Fund, LP (8.70%), Ortav Yehudai (8.70%)
11,454,0008.70%13G (passive)Feb 17, 2026
Alyeska Investment Group, L.P.
Joint filing with Alyeska Fund GP, LLC (9.35%), Anand Parekh (9.35%)
11,250,0009.35%13G (passive) amendmentSep 30, 2025
Adage Capital Management, L.P.
Joint filing with Robert Atchinson (9.99%), Phillip Gross (9.99%)
10,479,3379.99%13G (passive) amendmentJun 30, 2025
Wilmot B. Harkey
Joint filing with Nantahala Capital Management, LLC (8.22%), Daniel Mack (8.22%)
10,378,4068.22%13G (passive) amendmentDec 31, 2025
abrdn Inc
Joint filing with Aberdeen Group plc (8.60%)
8,243,9418.60%13G (passive)Jun 30, 2025
abrdn Inc.
Joint filing with Aberdeen Group plc (6.85%)
8,243,9416.85%13G (passive) amendmentDec 31, 2025
683 Capital Management, LLC
Joint filing with 683 Capital Partners, LP (5.90%), Zweiman Ari (5.90%)
7,500,0005.90%13G (passive) amendmentDec 31, 2025
Anand Parekh
Joint filing with Alyeska Investment Group, L.P. (6.24%), Alyeska Fund GP, LLC (6.24%)
7,500,0006.24%13G (passive) amendmentDec 31, 2025
Soleus Capital Master Fund, L.P.
Joint filing with Soleus Capital, LLC (5.50%), Soleus Capital Group, LLC (5.50%) and 3 more
6,792,0005.50%13G (passive)Feb 17, 2026
Avidity Partners Management (Gp) LLC
Joint filing with Avidity Partners Management LP (6.60%), Avidity Capital Partners Fund (Gp) LP (6.60%) and 3 more
6,041,0596.60%13G (passive) amendmentMar 31, 2025
Avidity Partners Management LP
Joint filing with Avidity Partners Management (GP) LLC (5.90%), Avidity Capital Partners Fund (GP) LP (5.90%) and 2 more
5,615,8115.90%13G (passive) amendmentJun 30, 2025
Michael Kramarz
Joint filing with Commodore Capital LP (9.90%), Commodore Capital Master LP (9.90%) and 1 more
1,511,8219.90%13G (passive) amendmentJun 30, 2026
Aberdeen Group plc
Joint filing with abrdn Inc. (7.99%)
1,090,4277.99%13G (passive) amendmentSep 30, 2026
Nantahala Capital Management, LLC
Joint filing with Wilmot B. Harkey (7.47%), Daniel Mack (7.47%)
1,079,8437.47%13G (passive) amendmentJun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of IMUXValueChange% of portfolio
abrdn plc824,3936.04%$12.67M−10.02%
Bvf Inc/Il765,2955.61%$11.76M−20.30%
Millennium Management LLC740,3475.43%$11.38M+362,3550.00%
Avidity Partners Management LP669,9414.91%$10.30M−66,9941.65%
Braidwell LP645,0104.73%$9.91MNew0.37%
Laurion Capital Management LP610,3264.47%$9.38M+222,1100.24%
Vanguard Capital Management LLC571,5614.19%$8.78M+57,7290.00%
Jones Hill Capital LP539,8143.96%$8.30MNew1.76%
Nantahala Capital Management, LLC501,2923.67%$7.70M+250,6430.13%
Woodline Partners LP471,5283.46%$7.25M+374,8130.02%
Soleus Capital Management, L.P.450,0003.30%$6.92M–0.24%
Propel Bio Management, LLC325,0222.38%$5.00M+90,5442.61%
UBS Group AG175,7561.29%$2.70M+123,4760.00%
Geode Capital Management, LLC170,6751.25%$2.62M+18,0980.00%
683 Capital Management, LLC147,2451.08%$2.26M−97,7550.11%
Adage Capital Partners Gp, L.L.C.139,8601.03%$2.15M–0.00%
BlackRock, Inc.132,7910.97%$2.04M+36,3680.00%
Marshall Wace, Llp104,8160.77%$1.61M+9,5190.00%
Susquehanna International Group, Llp90,8900.67%$1.40M−11,9350.00%
Jane Street Group, LLC89,6870.66%$1.38M+23,7720.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026559M63.7%11 / 2415 / 333M1M
Q1 2026787M48.1%33 / 207 / 143M1M
Q4 2025605M37.6%9 / 169 / 91M0M
Q3 2025614M31.3%14 / 1010 / 90M1M
Q2 2025565M36.8%5 / 1514 / 141M1M
Q1 2025654M29.7%12 / 1118 / 140M2M
Q4 2024675M39.0%12 / 2016 / 61M1M
Q3 2024626M41.0%12 / 1714 / 51M0M
Q2 2024576M40.9%4 / 1517 / 80M0M
Q1 2024616M42.1%21 / 197 / 104M0M
Q4 2023502M11.1%7 / 1314 / 100M0M
Q3 2023542M13.5%4 / 1419 / 140M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

19 funds held IMUX in Q2 2026, 80% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of IMUXValue% of fundAs of
Vanguard Total Stock Market Index Fund399,0882.92%$6.13M0.00%Jun 30, 2026
Vanguard Extended Market Index Fund159,2481.17%$2.45M0.00%Jun 30, 2026
Fidelity Extended Market Index Fund63,0100.46%$942.63K0.00%May 31, 2026
iShares Micro-Cap ETF46,2430.34%$710.75K0.05%Jun 30, 2026
Simplify Propel Opportunities ETF30,7250.23%$472.24K0.61%Jun 30, 2026
Fidelity Total Market Index Fund29,2530.21%$437.62K0.00%May 31, 2026
Fidelity Series Total Market Index Fund17,8080.13%$266.41K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund9,8390.07%$147.19K0.00%May 31, 2026
Schwab Total Stock Market Index Fund8,5000.06%$118.75K0.00%Jul 31, 2026
Fidelity ZERO Total Market Index Fund8,0370.06%$112.28K0.00%Jul 31, 2026
Vanguard Institutional Total Stock Market Index Fund6,9930.05%$107.48K0.00%Jun 30, 2026
Vanguard Balanced Index Fund6,2320.05%$95.79K0.00%Jun 30, 2026
Fidelity ZERO Extended Market Index Fund5,1540.04%$72.00K0.00%Jul 31, 2026
1290 VT Micro Cap Portfolio3,1210.02%$47.97K0.02%Jun 30, 2026
Fidelity Flex Small Cap Index Fund2,2070.02%$30.83K0.01%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Duane NashExecutive Chairman, Director45,2560.33%Jul 18, 2025
Jason TardioPresident and COO12,5120.09%Jun 29, 2026
Glenn WhaleyChief Financial Officer95,5100.70%Jun 29, 2026
Erik LundgrenChief Executive Officer––Jun 1, 2026
Michael A. PanzaraChief Medical Officer––Apr 29, 2026
Andreas MuehlerChief Medical Officer582,4664.27%Jul 18, 2025
Value Trading Fund OS LP BiotechnologyDirector427,6293.13%Sep 18, 2026
Partners L. P/Il BvfDirector––Sep 18, 2026
Value Fund L. P. BiotechnologyDirector––Sep 18, 2026
Partners OS Ltd. BVFDirector––Sep 18, 2026
Ii Gp Llc BvfDirector––Sep 18, 2026
Robert Thorvald NagelDirector––Sep 18, 2026
Value Fund Ii Lp BiotechnologyDirector––Sep 18, 2026
I. Gp Llc BvfDirector––Sep 18, 2026
Inc/Il BvfDirector––Sep 18, 2026
Mark N. LampertDirector––Sep 18, 2026
Gp Holdings Llc BvfDirector42,7620.31%Sep 18, 2026
Elena RidloffDirector––Aug 10, 2026
Jon CongletonDirector––Jul 7, 2026
Richard Alan RudickDirector230,3751.69%Jul 7, 2026
Barclay A. PhillipsDirector––Jul 7, 2026
Joerg NeermannDirector200,0001.47%Jul 7, 2026
Simona SkerjanecDirector––Jul 7, 2026
Michael W. BonneyDirector––Jun 29, 2026
Daniel VittDirector391,8772.87%Jun 29, 2026
Tamar D. HowsonDirector––Jun 29, 2026
Monika Maria ToernsenDirector––Jun 9, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Duane Nash
Executive Chairman, Director
Jun 13, 2025Buy+20,000$0.83$16.60K36,032
Jason Tardio
President and COO
Jun 5, 2025Buy+12,512$0.79$9.88K12,512
Jason Tardio
President and COO
Jun 5, 2025Buy+12,512$0.79$9.88K12,512
Joerg Neermann
Director
Jun 5, 2025Buy+30,000$0.76$22.80K200,000
Daniel Vitt
CEO and Director
Jun 4, 2025Buy+15,000$0.77$11.55K29,000
Daniel Vitt
CEO and Director
Jun 4, 2025Buy+15,000$0.77$11.55K29,000
Joerg Neermann
Director
Jun 4, 2025Buy+70,000$0.77$53.90K170,000
Glenn Whaley
Chief Financial Officer
Jun 3, 2025Buy+45,000$0.71$31.95K95,510
Richard Alan Rudick
Director
Jun 3, 2025Buy+143,075$0.70$100.15K230,375
Glenn Whaley
Chief Financial Officer
May 30, 2025Award+25,000$0.56$14.00K50,510
Richard Alan Rudick
Director
Nov 12, 2024Buy+87,300$1.15$100.39K87,300
Daniel Vitt
President and CEO, Director
Feb 26, 2024Buy+14,000$1.31$18.34K390,877
Glenn Whaley
Chief Financial Officer
May 15, 2023Buy+5,000$1.75$8.75K25,510
Joerg Neermann
Director
Dec 14, 2022Buy+47,000$1.26$59.22K100,000
Joerg Neermann
Director
Dec 13, 2022Buy+35,000$1.25$43.75K53,000
Joerg Neermann
Director
Nov 23, 2022Buy+18,000$1.39$25.02K18,000
Daniel Vitt
President and CEO, Director
Nov 22, 2022Buy+8,000$1.35$10.80K376,877
Glenn Whaley
Chief Financial Officer
Nov 7, 2022Buy+5,000$1.50$7.50K20,510
Daniel Vitt
President and CEO, Director
Jun 3, 2022Buy+5,000$3.10$15.50K368,877
Glenn Whaley
Chief Financial Officer
Jun 3, 2022Buy+3,500$3.05$10.68K12,568
Andreas Muehler
Chief Medical Officer
May 12, 2022Buy+3,500$5.10$17.85K297,986
Glenn Whaley
Chief Financial Officer
May 12, 2022Buy+3,000$5.08$15.24K9,068
Duane Nash
Executive Chairman, Director
May 12, 2022Buy+10,000$5.03$50.30K22,032
Duane Nash
Executive Chairman, Director
May 12, 2022Gift−6,000––16,032
Duane Nash
Executive Chairman, Director
Nov 8, 2021Gift−3,000––12,032
Daniel Vitt
President and CEO, Director
Aug 10, 2021Buy+1,000$9.60$9.60K363,877
Duane Nash
Executive Chairman, Director
Aug 10, 2021Buy+1,000$9.80$9.80K15,032
Glenn Whaley
PFO and PAO
Aug 10, 2021Buy+1,500$9.85$14.78K3,500
Duane Nash
Executive Chairman, Director
May 12, 2021Buy+4,000$12.75$51.00K14,032
Andreas Muehler
Chief Medical Officer
Mar 2, 2021Buy+10,006$15.54$155.49K294,486
Glenn Whaley
PFO and PAO
Mar 2, 2021Buy+1,000$16.48$16.48K2,000
Glenn Whaley
PFO and PAO
Aug 10, 2020Buy+1,000$18.96$18.96K1,000
Manfred Groeppel
Chief Operating Officer
Jul 21, 2020Sale(10b5-1 plan)−650$15.62$10.15K278,830
Daniel Vitt
Chief Executive Officer, Director
Jul 21, 2020Sale(10b5-1 plan)−1,300$15.62$20.31K362,877
Manfred Groeppel
Chief Operating Officer
Jul 20, 2020Sale(10b5-1 plan)−5,000$14.44$72.20K279,480
Daniel Vitt
Chief Executive Officer, Director
Jul 20, 2020Sale(10b5-1 plan)−5,000$14.44$72.20K364,177
Duane Nash
Director
Dec 4, 2019Sale(10b5-1 plan)−4,400$6.96$30.62K10,032
Duane Nash
Director
Dec 3, 2019Tax withholding−7,930$7.15$56.70K14,432
Duane Nash
Director
Dec 2, 2019Option exercise+22,157––22,362
Errol R. Halperin
Director
Sep 25, 2018Sale−89,417$0.29$25.93K0
Errol R. Halperin
Director
Sep 25, 2018Sale−10,000$0.29$2.90K0
Jean Jacques Bienaime
Director
Sep 24, 2018Sale−26,619$0.30$7.99K18,500
Douglas Evan Godshall
Director
Sep 19, 2018Sale−69,375$0.35$24.28K0
Muneer A. Satter
Director, 10% owner
Sep 17, 2018Sale−7,044,777$0.29$2.04M0
Muneer A. Satter
Director, 10% owner
Sep 14, 2018Sale−447,500$0.36$161.10K7,044,777
Faheem Hasnain
Director
Sep 13, 2018Sale−59,200$0.44$26.05K122,743
Faheem Hasnain
Director
Sep 13, 2018Sale−118,243$0.44$52.03K4,500
Jean Jacques Bienaime
Director
Sep 13, 2018Sale−20,000$0.47$9.40K45,119
Muneer A. Satter
Director, 10% owner
Sep 13, 2018Sale−3,890,000$0.50$1.95M7,492,277
Cheryl Cohen
Director
Sep 12, 2018Sale−3,500$0.55$1.93K0
Muneer A. Satter
Director, 10% owner
Dec 13, 2017Buy+50,000$5.57$278.50K11,382,277
Muneer A. Satter
Director, 10% owner
Dec 12, 2017Buy+50,000$5.40$270.00K11,332,277
Muneer A. Satter
Director, 10% owner
Dec 11, 2017Buy+50,000$4.96$248.00K11,282,277
Muneer A. Satter
Director, 10% owner
Dec 8, 2017Buy+50,000$4.92$246.00K11,232,277
Muneer A. Satter
Director, 10% owner
Dec 7, 2017Buy+50,000$4.77$238.50K11,182,277
Faheem Hasnain
Director
Sep 14, 2017Buy+59,200$4.19$248.05K181,943
Muneer A. Satter
Director, 10% owner
Sep 14, 2017Buy+30,000$4.25$127.50K11,132,277
Muneer A. Satter
Director, 10% owner
Sep 13, 2017Buy+50,000$4.13$206.50K11,102,277
Jean Jacques Bienaime
Director
Sep 13, 2017Buy+10,000$4.00$40.00K65,119
Muneer A. Satter
Director, 10% owner
Sep 12, 2017Buy+50,000$3.74$187.00K11,052,277

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
14.29%
2M shares short
Days to cover
5.7
At 0M shares a day
Change since last report
+4.8%
From 2M shares
Short volume, 20 days
50.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Immunic's stock actually held short. Settlement fails (shares not delivered on time) peaked at 8,554 shares on Aug 31, 2026 over the last 90 days.

See a number that looks wrong?